|
HS Code |
960111 |
As an accredited Tert-Butyl 4-Bromobutyrate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive Tert-Butyl 4-Bromobutyrate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Science often finds its momentum in practical solutions to tricky problems. In the labs and production facilities where new pharmaceuticals and specialty materials come to life, even small differences in chemical structure can mean the difference between a stalled project and a breakthrough discovery. Tert-Butyl 4-Bromobutyrate belongs in that category of unsung molecular heroes, those foundational intermediates that run quietly behind the scenes, powering robust synthetic pathways and offering flexibility to chemists looking for both reliability and versatility.
Every chemist will agree: not all reagents are built the same. In my own work, selection of a reagent such as Tert-Butyl 4-Bromobutyrate (CAS: 61344-70-7, molecular formula C8H15BrO2, molecular weight: 223.11 g/mol) reflects a deliberate choice to prioritize certain outcomes. There's value in knowing how a tert-butyl protected ester behaves compared to, say, a methyl or an ethyl analog. The tert-butyl group on this molecule does more than pad the molecular weight—it offers stability during certain reactions, holding tight while harsh acids or bases would usually bring less robust esters to their knees.
I've worked through enough reaction setups to appreciate what the “4-bromo” position adds. Here’s the gist: the bromide tends to serve as an accessible leaving group, which opens plenty of doors for nucleophilic substitution. Whether the goal is to introduce a new functionality or to prepare for further expansion of a molecular scaffold, having that bromine in the terminal position often lets you extend your reach. Compared with its close cousins—like ethyl 4-bromobutyrate or methyl 4-bromobutyrate—the tert-butyl variant shields the carboxyl end, making it less likely to scramble in basic or acidic media during multistep syntheses.
My own early days in organic synthesis taught me the value of functional group protection. Stepping through multi-stage reactions with both hands tied by unstable intermediates can be an exercise in frustration. Tert-butyl esters, particularly in the 4-bromobutyrate configuration, are prized for their resilience under many conditions. Removing the tert-butyl group later, using reagents like trifluoroacetic acid, isn’t tricky. The product comes free without much fuss—this is a benefit that can spare weeks of troubleshooting, especially when dealing with sensitive molecules where methyl or ethyl esters would break apart too soon.
Industry chemists, especially those working in small- to medium-scale batch production, find value in this intermediate’s balance of reactivity and bench stability. In pharmaceutical discovery, synthetic flexibility is gold. With its reactive bromide and protected carboxyl, Tert-Butyl 4-Bromobutyrate becomes a go-to building block for custom molecule design, advanced intermediates, prodrugs, or even polymer conjugates.
There's a thriving trade in variants of 4-bromobutyrate esters. What sets the tert-butyl ester apart is the particular suitability for sequences where temporary protection is needed. In my experience, the methyl and ethyl versions show up when removal isn’t planned or when gentle conditions are unavoidable. The tert-butyl group offers selective deprotection—once the rest of the molecule is fully built, it can be removed in one straightforward step. That’s a big deal when working on sensitive intermediates or in ventures that demand atom economy, fewer purification steps, or integration of green chemistry.
Comparing with other brominated esters, say, benzyl or cyclohexyl analogs, tert-butyl’s bulk uniquely prevents side-reactions during strong base treatment. I once constructed a series of β-amino acids where tert-butyl esters gave much higher yields than methyl or benzyl. Those who routinely scale reactions know how crucial reliable protection is, especially when a single failed batch could mean a missed production deadline.
Nobody gets far in medicinal chemistry without bumping into tough-to-protect carboxylic acids. There’s a reason why tert-butyl esters take up so much shelf space in research labs. In the synthesis of prodrugs, the choice of this protection strategy often means a smoother process and easier purification. For example, the route from Tert-Butyl 4-Bromobutyrate to γ-aminobutyric acid (GABA) analogs wouldn’t see such widespread use if a less stable ester blocked the way.
Process chemists in pharma and biotech prize this compound for late-stage functionalization. During the optimization of new routes for active pharmaceutical ingredients (APIs), it's common to experiment with several protecting groups. The tert-butyl on this molecule reliably drops off without impacting diverse functional groups elsewhere. Unlike more labile esters, which can complicate purification, the tert-butyl version stays put, even through tricky transformations involving strong bases or nucleophiles.
Polymer research teams have also benefited. Using Tert-Butyl 4-Bromobutyrate in combination with controlled radical polymerization techniques allows for precise placement of user-defined functionalities. The bromine acts as a handle for subsequent modifications, which lets you stitch in side-chains or end-groups with a high level of control. This chemical's solid performance in varied reaction conditions makes it ideal for this kind of work.
In my years in lab settings, I found Tert-Butyl 4-Bromobutyrate to be a pale, sometimes faintly yellow liquid. It has a reliable boiling point, which helps when setting up distillation—fewer unwanted surprises, fewer hours wasted tracking down impurities. Its density lands close to 1.174 g/mL at room temperature, which matters when measuring out for scale-up. On storage, it holds up well under inert atmosphere in cool, dry spaces, though you can expect it to eventually go off if you leave it unsealed or out in the bright sun for long.
Small labs and production-scale facilities both find its moderate solubility in common organic solvents—dichloromethane, ethyl acetate, and ether—to be a plus. The bromine atom adds some heft, making it easier to spot on TLC plates or in NMR spectra during reaction monitoring. Once, during a scale-up process, the clarity in tracking conversion, simply from visual and analytical cues of this molecule, saved time and cut costs on unnecessary testing.
As with many organobromides, direct exposure can bring skin irritation, and inhaling vapors is a known risk, so basic lab PPE—gloves, splash goggles, and lab coats—are standard. In production settings, fume hoods and good ventilation handle the rest. Some safety data sheet recommendations may seem redundant, but after seeing a careless spill in a teaching lab, I’ll always respect the reactivity of the bromide group.
In my own decision-making, I weigh the value of the tert-butyl ester not just against ease of removal, but in the broader context of what’s planned downstream. If I’m targeting a multi-step synthesis where harsh acidic or basic steps lurk, I lean on tert-butyl for stability. If scaling up, I look for compounds with resilience in storage, and this ester generally fits the bill. Colleagues working in custom synthesis have echoed the same: when the need is for both a temporary mask and reactivity at the terminal bromine, Tert-Butyl 4-Bromobutyrate stands out.
The molecule’s place in chemical catalogs owes as much to these practical advantages as to its solid track record in literature. You don’t have to chase down niche vendors for project-scale quantities—the compound is broadly available in purity levels fit for exploratory and process R&D. Having used several batches across commercial suppliers, I find product consistency to be better than many less common esters or halides—a small but meaningful edge when working under tight project timelines.
Any honest look at protecting groups has to include their downside. The tert-butyl group is bulkier than others, which can sometimes hinder certain reactions by increasing steric hindrance near the reactive site. In practice, though, I’ve rarely found that to tip the scales against its use, especially if the route demands strong conditions somewhere along the way.
Alternative bromobutyrates such as the methyl and ethyl versions may offer faster reaction rates in some nucleophilic substitutions, given their smaller size. I’ve seen cases where this tipped things for small-molecule aromatic compounds, leading to minor gains in yield or reaction speed. Yet, during scale-up, the need for robustness—in storage, purification, and downstream deprotection—often wipes out such narrow advantages. For research teams mindful of waste, those extra purification steps with more labile esters add up, both in time and solvent use.
Some researchers shy away from tert-butyl esters, citing the need for specific acids to cleave the group at the end. In medicinal chemistry, though—where isolation of final products with full integrity matters most—these extra steps can amount to an insurance policy. A couple of hours spent on deprotection can prevent days or weeks lost to product instability or low yields.
Over the past decade, chemical supply chains have undergone big shifts, especially for intermediates that feed directly into pharmaceutical and advanced material pipelines. Tert-Butyl 4-Bromobutyrate shows up frequently as a “must-have” in advanced searches for custom synthesis projects. Given the growing role of specialty building blocks in new drug design and the rise of tailor-made polymers, its presence in catalog listings reflects more than statistical demand—it demonstrates a track record of utility for a growing community of innovators.
I remember one project where pandemic-era supply disruptions meant planning synthesis with only those building blocks that could be sourced from more than one vendor. Tert-Butyl 4-Bromobutyrate proved an asset precisely because of how commonly it shows up with robust documentation—MSDS, COA, and spectral data are almost always in hand, making regulatory review and pilot batches easier to manage.
Looking toward the future, the push toward green chemistry means every intermediate will get a fresh look. Tert-butyl esters already have an edge here, since their removal typically needs less aggressive conditions or generates fewer by-products compared to some alternatives. I’ve been involved in projects where solvent reduction and process intensification were the goals—the tert-butyl intervention not only eased purification but also limited the environmental impact by cutting down hazardous waste. The options for deprotection using strong acids are both cost-effective and scalable, which aligns well with the lean principles in modern fine chemical production.
The bromine atom, for all its reactivity and utility, does raise questions about end-of-life disposal and potential health concerns. I’d recommend organizations routinely review such intermediates against growing regulatory frameworks in both the US and EU, as halogenated by-products have drawn more scrutiny over the last few years. Forward-thinking groups tend to invest in closed-loop production lines, limiting the release of brominated materials, and in developing safer quenching protocols for waste streams. In my experience, a little investment in upfront planning can prevent larger compliance risks down the line.
Ongoing research into new protecting group strategies and alternative halogenations could yield even more flexible versions of Tert-Butyl 4-Bromobutyrate in the years ahead. My conversations with materials scientists and medicinal chemists suggest interest is growing in fluorinated analogs and “smart” protecting groups that respond to novel deprotection triggers—light, electricity, or enzymes. Still, for now, the classic tert-butyl/bromo combination carries the day, delivering solid results in both academic and commercial settings.
Anyone considering process upgrades—continuous flow reactors, greener solvents, or real-time analytics—will find that Tert-Butyl 4-Bromobutyrate adapts well to such modernizations. Implementing real-time reaction monitoring, using simple techniques like benchtop NMR or IR, further streamlines workups and quality control. This intermediate supports both innovation and operational stability—qualities that count whether you’re in a startup or an established firm.
Chemical manufacturing often walks a tightrope between efficiency and creativity. Intermediates like Tert-Butyl 4-Bromobutyrate help smooth that path. By offering both a robust protecting group and a conveniently placed bromine, it enables synthesis plans that are shorter, cleaner, and more adaptable. Research programs accelerate, costs come under control, and troubleshooting shrinks. These are the real wins, born from thoughtful product selection and grounded in daily lab realities.
Thanks to steady reliability, good availability, and operational flexibility, Tert-Butyl 4-Bromobutyrate earns its place in the toolkit of working chemists. Whether you’re mapping a synthetic route for a new molecule, shifting old processes onto greener technologies, or troubleshooting at the bench, this compound delivers value and stability where it counts.